Three years ago, 23andMe, a DNA testing company, was a huge success and had a higher share price than Apple.
However, since the heyday when millions of people flocked to submit saliva samples to obtain comprehensive studies about their genetic composition, family relationships, and heritage, it is now struggling to survive.
This week, it just missed being delisted from the stock market, and its share price has fallen precipitously.
It goes without saying that this business has the most private information about its clients, which raises alarming concerns about what might happen to its enormous and incredibly valuable database of unique human DNA.
